Early clinical outcomes data for adjunctive systemic sirolimus therapy (SST) for moderate to severe pediatric pulmonary vein stenosis (PVS) are promising but limited. The authors aimed to characterize a cohort of patients treated with SST to determine if SST was associated with a reduction in frequency of PVS interventions. Medical records of 45 patients with PVS treated with SST for ≥1 month from 2015 to 2022 were retrospectively reviewed. PVS intervention rates pre-SST and on-SST were compared using generalized Poisson mixed models, accounting for paired intervals within each patient. In addition to an unadjusted model, an adjusted model accounted for age at interval start, PVS type, sex, prematurity, and concurrent antiproliferative therapy. Mean number of PVS interventions per patient over time (mean cumulative function) were also compared for these intervals in an unpaired fashion. Kaplan-Meier estimates were used to quantify survival over time. Median per-patient PVS intervention rate (interventions/year) was 5 pre-SST and 1.7 on-SST, significantly lower on-SST in the unadjusted and adjusted models (P < 0.001, both). Patients accrued an increased cumulative number of interventions over time pre-SST compared to on-SST by mean cumulative function (P < 0.001). Median duration of SST was 1.7 years and median follow-up time from SST initiation was 2.7 years. There were 6 mortalities at a median of 1.1 years (range, 4.4 months-6.5 years) following SST initiation. SST was associated with a reduction in frequency of PVS interventions. Prospective studies are warranted to determine potential causality, delineate patient- and vein-level outcomes, and determine optimal therapeutic duration.
Computer simulations of blood flow in patients with anomalous aortic origin of a coronary artery (AAOCA) have the promise to provide insight into this complex disease. They provide an in silico experimental platform to explore possible mechanisms of myocardial ischemia, a potentially deadly complication for patients with this defect. This paper focuses on the question of model calibration for fluid-structure interaction models of pediatric AAOCA patients. Imaging and cardiac catheterization data provide partial information for model construction and calibration. However, parameters for downstream boundary conditions needed for these models are difficult to estimate. Further, important model predictions, like fractional flow reserve (FFR), are sensitive to these parameters. We describe an approach to calibrate downstream boundary condition parameters to clinical measurements of resting FFR. The calibrated models are then used to predict FFR at stress, an invasively measured quantity that can be used in the clinical evaluation of these patients. We find reasonable agreement between the model predicted and clinically measured FFR at stress, indicating the credibility of this modeling framework for predicting hemodynamics of pediatric AAOCA patients. This approach could lead to important clinical applications since it may serve as a tool for risk stratifying children with AAOCA.
The study objective was to describe a deployment technique of the Gore Cardioform atrial septal defect (ASD) occluder (W.L. Gore and Associates) for large secundum ASDs and ASDs with challenging anatomy. from Journal of Invasive Cardiology. Atrial septal defect Congenital heart disease pediatrics structural heart disease intervention
Vascular access-related complications are an important consideration in patients undergoing cardiac catheterisation. Patients with CHD are increasingly undergoing percutaneous treatment for suitable procedures as an alternative, less invasive option to surgical intervention. As such, recognition and treatment of these complications are becoming increasingly important. We present a case of a patient with repaired Tetralogy of Fallot who developed a femoral arteriovenous fistula and femoral artery pseudoaneurysm arising from an accessory arterial branch following percutaneous Harmony valve implantation, both of which were treated endovascularly with placement of a stent.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population. Original Contribution from Journal of Invasive Cardiology. Coronary Artery Anomalies Intravascular ultrasound IVUS myocardial bridge